In our study, zinc oxide (ZnO) nanoparticles (NPs) were prepared by precipitation (economically and in high quality) at a temperature range of 60°C to 80°C and at pH 8, and were then adorned with graphene (G) plates. To determine its antimicrobial potential, the ZnO/G complex was loaded with metronidazole. The morphology and diameter of the ZnO nanocomposite before and after the loading were validated by scanning electron microscopy. The average size of the ZnO NPs was found to be 20–40 nm, while X-ray diffraction examined how the physical features of these NPs varied from those of its individual components with an average size of 28.1 nm. The assessment of the ZnO/G com¬plex’s antibacterial efficacy against Gram-positive and Gram-negative bacteria was the main aim of our work. The agar well diffusion technique was used in order to assess the antibacterial activity of the ZnO/G complex with and without metronidazole. Our study demonstrates that the ZnO/G complex possesses antibacterial activity and might increase the antibiotic action by inhibiting Gram-positive bacteria (more than Gram-negative ones). It is, therefore, concluded that the ZnO/G NPs could be of use in formulating nano-drug conjugates that could act as antimicrobial agents.
5 May 2024 in Review of Clinical Pharmacology and Pharmacokinetics - International Edition
Smart nanopolymers with the capability to release drugs on demand and in response to specific illness signals, rep¬resent a promising avenue in the field of drug delivery. Their synthesis and characterization process involves the careful design of nanopolymeric structures, incorporating stimuli-responsive elements. The responsiveness of these nanopolymers to specific illness signals is evaluated through in vitro studies that simulate physiological conditions. The potential of these nanopolymers is explored in the context of personalized medicine, where tailored drug delivery systems respond to individual patient needs. The characterization of these smart nanopolymers showcases their po¬tential as a novel and effective approach for on-demand drug release in response to illness signals. The findings contribute to the advancement of precision medicine and the development of innovative drug delivery systems with enhanced therapeutic efficacy and reduced side-effects.
In this study, the chemical reduction technique was utilized to create a three-phase nanocomposite system including metallic copper (Cu 0 ), cupric oxide (CuO, Cu 2+ ), and cuprous oxide (Cu 2 O, Cu + ) inside a single matrix in one step.